title: Application of Induced Pluripotent Stem Cell Technology to the Study of Hematological Diseases.
abstract: The burst of reprogramming technology in recent years has revolutionized the field of stem cell biology, offering new opportunities for personalized, regenerative therapies. The direct reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) has provided an invaluable tool to study and model a wide range of human diseases. Here, we review the transforming potential of such a strategy in research and in therapies applicable to the hematology field.
authors.affiliation: Department of Translational Medicine, University of Eastern Piedmont, Novara 28100, Italy. mailin.li@med.uniupo.it.
authors.forename: Mailin
authors.initials: M
authors.lastname: Li
authors.affiliation: Department of Translational Medicine, University of Eastern Piedmont, Novara 28100, Italy. pasquale.cascino@med.uniupo.it.
authors.forename: Pasquale
authors.initials: P
authors.lastname: Cascino
authors.affiliation: Department of Translational Medicine, University of Eastern Piedmont, Novara 28100, Italy. simone.ummarino@uniupo.it.
authors.forename: Simone
authors.initials: S
authors.lastname: Ummarino
authors.affiliation: Department of Translational Medicine, University of Eastern Piedmont, Novara 28100, Italy. annalisa.diruscio@med.uniupo.it.
authors.forename: Annalisa
authors.initials: A
authors.lastname: Di Ruscio
keywords: blood diseases; cancer; regenerative medicine; reprogramming